These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30467801)

  • 21. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.
    Fioretto P; Caramori ML; Mauer M
    Diabetologia; 2008 Aug; 51(8):1347-55. PubMed ID: 18528679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study.
    Yu Y; Zhu C; Lin Y; Qian Q; Shen X; Zou W; Wang M; Gong J; Chen M; Liu L; Yu R; Shen Q; Shao L; Zhu B
    Ren Fail; 2023; 45(2):2285868. PubMed ID: 38013428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features and outcomes of diabetic kidney disease with extracapillary hypercellularity: a Japanese single-center experience.
    Saito A; Komatsuda A; Saito M; Kaga H; Abe F; Sawamura M; Nara M; Sato R; Wakui H; Takahashi N
    Clin Exp Nephrol; 2020 Jun; 24(6):509-517. PubMed ID: 32037471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
    Wu Y; Zhang J; Wang Y; Wang T; Han Q; Guo R; Zhang R; Ren H; Zhu Y; Xu H; Li L; Tong N; Liu F
    J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification.
    Stefan G; Stancu S; Zugravu A; Petre N; Mandache E; Mircescu G
    Medicine (Baltimore); 2019 Jul; 98(27):e16333. PubMed ID: 31277183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
    Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
    J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus.
    Zhao L; Li L; Ren H; Zou Y; Zhang R; Wang S; Xu H; Zhang J; Liu F
    Ren Fail; 2020 Nov; 42(1):818-828. PubMed ID: 32781868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
    Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
    Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China.
    Zhu X; Xiong X; Yuan S; Xiao L; Fu X; Yang Y; Tang C; He L; Liu F; Sun L
    J Diabetes Complications; 2016 Apr; 30(3):537-41. PubMed ID: 26796433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy.
    Mise K; Hoshino J; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Ohashi K; Hara S; Takaichi K
    Nephrol Dial Transplant; 2014 Jan; 29(1):109-18. PubMed ID: 24151019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THE ASSOCIATION OF SERUM BILIRUBIN ON KIDNEY CLINICOPATHOLOGIC FEATURES AND RENAL OUTCOME IN PATIENTS WITH DIABETIC NEPHROPATHY: A BIOPSY-BASED STUDY.
    Wu Y; Zhang J; Wang J; Wang Y; Han Q; Li H; Wang T; Liu F
    Endocr Pract; 2019 Jun; 25(6):554-561. PubMed ID: 30865534
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
    J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
    Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
    Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.